Moderna, Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the Uni…
Biotechnology
US, Cambridge [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 1 | $3,000,000 | LD-2 : 04/02/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/22/24 |
| 2023 | 4 | $4,500,000 | LD-2 : 01/22/24 |
| 2023 | 4 | $8,000,000 | LD-2 : 01/18/24 |
| 2023 | 4 | $3,000,000 | LD-2 : 01/11/24 |
Get PRO Today
With PRO you will unlock 13 more lobbying disclosures for Moderna, Inc.